CYDY Company Profile

CYDY Time & Sales

CYDY Recent News

CYDY Filings

CYDY Financials

CYDY Buy Rating

twinter11

07/24/2025 8:00:33 PM

"No More shareholders communicating (3)

cardamine

07/24/2025 7:12:11 PM

YES to Sean - No More shareholders (19)

sean007

07/24/2025 5:49:39 PM

We hired our players to play...let them (9)

Figgs

07/24/2025 4:31:21 PM

So RFK Jr seems totally obsessed with (2)

sunray3

07/24/2025 1:58:43 PM

Well said. Free (2)

Buddyboy20

07/24/2025 10:47:19 AM

Apparently, Colorectal Cancer (CRC) (19)

PennySlayer

07/24/2025 10:34:58 AM

They also have not signed an office (1)

hoops

07/24/2025 10:11:22 AM

Sorry. Must be a glitch on Schwab. (1)

hoops

07/24/2025 9:34:26 AM

The manipulation gets ridiculous. 18K (1)

Hyperbolic

07/24/2025 9:08:36 AM

Would you care to (2)

pnwtri

07/24/2025 8:22:16 AM

Pestell is going to bring this thing (4)

HHIGambler

07/24/2025 6:05:46 AM

I sent the link to the admin and (2)

ohm20

07/24/2025 4:06:45 AM

What does this mean? That he needs a (5)

skezan

07/23/2025 11:31:55 PM

CNPV fun facts: FAQs: Commissioners (8)

HouseofCards

07/23/2025 9:39:53 PM

We can still sell like 250M shares if (2)

mfglola

07/23/2025 9:11:09 PM

So FDA is now accepting applications (8)

biloxiblues

07/23/2025 8:29:23 PM

We will be fine! (2)

sean007

07/23/2025 8:01:14 PM

Money is never out of (4)

Mr3Putt

07/23/2025 6:35:43 PM

Thoughts? Upwithstock IIRC has (5)

bucweey34

07/23/2025 6:08:28 PM

Question for those with more knowledge (1)

Buddyboy20

07/23/2025 5:50:30 PM

"I still vividly remember the sharp (8)

sean007

07/23/2025 5:43:23 PM

"Beneath the surface"...remains the (1)

KenChowder

07/23/2025 5:29:34 PM

Sherlock, companies who make tender (6)

sjacobs26

07/23/2025 4:41:02 PM

I could be off here, but considering (10)

sherlock57

07/23/2025 3:57:35 PM

Sunray--Imagine the response of the (18)

cardamine

07/23/2025 3:07:08 PM

Wiki even makes a separate section for (2)

cardamine

07/23/2025 2:53:12 PM

yeah there's been the proverbial "blood (1)

sunray3

07/23/2025 1:12:31 PM

Oh, I'm sure as I suspect you are that (7)

twinter11

07/23/2025 12:57:30 PM

"I don't pretend to know the motives (7)

sunray3

07/23/2025 12:07:51 PM

Now mind you, I don't pretend to know (3)

sunray3

07/23/2025 11:11:08 AM

Definitely BS, you're right...the MM (7)

Tprovo

07/23/2025 10:43:31 AM

Gap filled at .28 this AM and so did my (2)

Evil Rabbit

07/23/2025 10:03:41 AM

That premarket action was some BS. 11k (6)

dfwl28

07/23/2025 9:55:10 AM

Side effects of Ipilimumab, also known (4)

ohm20

07/23/2025 4:01:10 AM

Ipilimumab Safety Profile: Associated (16)

ohm20

07/23/2025 3:50:15 AM

Based on above hypothesis, It could (11)

KenChowder

07/23/2025 3:13:18 AM

MGK wrote: Based on above hypothesis, (11)

ohm20

07/23/2025 2:56:21 AM

Sorry Ohm, I'm not smart enough to (13)

USS JOHNSTON

07/22/2025 11:27:56 PM

I am also not a doctor, biloxi, so I (5)

MGK_2

07/22/2025 8:09:36 PM

I wrote (4)

biloxiblues

07/22/2025 7:37:02 PM

I am not a Doctor, but this is (4)

craigakess

07/22/2025 7:24:09 PM

Thanks for posting the response. (5)

Mr3Putt

07/22/2025 7:05:07 PM

UWS responds to you at r/Livimmune: (3)

SeeWhyDY

07/22/2025 5:49:35 PM

Am I reading this article (2)

skezan

07/22/2025 4:42:55 PM

Sorry Ohm, I'm not smart enough to (2)

ohm20

07/22/2025 3:34:27 PM

Ipilimumab is an antibody that binds to (10)

craigakess

07/22/2025 1:50:53 PM

Thanks for posting that as it is quite (6)

craigakess

07/22/2025 1:36:36 PM

Strange that it says the study was (2)

sean007

07/22/2025 1:34:19 PM

Europe Not entire (1)

Boatbuilder

07/22/2025 1:15:30 PM

Unfortunately not CYDY. (2)

Newer

Older

Recent Articles

• Understanding Iron Mountain's Stock Growth Over Time
• Metsera's Response to Legal Challenges and Future Prospects
• Investigating Tandem Diabetes Care, Inc. for Misleading Claims
• Datavault AI Responds Strongly to Baseless Short Report Allegations
• Monolithic Power Systems: Surge in Stock Price Explained
• Amazing Growth Potential: Krystal Biotech's Investment Success
• Grupo Aeroportuario del Pacifico's Operations Update After Hurricane
• Incredible Growth: The Journey of Netflix Investments
• Understanding the P/E Ratio for CommScope Holdings
• Transforming Rental Housing: Canadian Commitment to Affordability
• Important Update on Data Security from Langdon & Emison LLC
• Join the Battle: Investors Unite Against Molina Healthcare Fraud
• PRFoods Reports Successful Transition with Improved Financials
• Discover the Growth of $1000 in Green Brick Partners Today
• Crown Racing Competes in Radical World Finals at VIR
• Imperial Metals Efficiently Settles Unsecured Debentures
• Dynamix Corporation III's Successful IPO: A Fresh Beginning
• Knight Therapeutics Secures $100 Million Credit Facility
• Consolidated Lithium Metals Strengthens Financing Strategy
• Aventis Energy Completes Significant Financing for Growth
• Gran Tierra Energy's Strategic Confirmation on i3 Energy Acquisition
• KBR Investors: Key Actions Ahead of Securities Class Action Deadline
• Understanding Ten Years of Investment Growth in Stryker Corp
• Investors Urged to Act: Important Class Action Info for JSPR
• SohoMD Seeks Investment to Enhance Mental Health Services
• Gran Tierra Energy Updates Investors on i3 Acquisition Status
• Caliber Announces Innovative Debt-to-Equity Conversion Efforts
• Summit Hotel Properties Announces Strong Dividend Payments
• AeroVironment Investment Growth: A Decade of Success
• MoonLake Immunotherapeutics Class Action Details and Impacts
• Springview Holdings Ltd's Appeal Against Nasdaq Delisting Notice
• Serena Neel Unveils Exciting Holiday Bathroom Series on TikTok
• A Deep Dive Into Royal Caribbean Group's Long-Term Stock Growth
• Knight Therapeutics Secures $100M Credit Facility for Growth
• Understanding Nutanix's Stock Valuation Through P/E Ratio
• Aventis Energy Closes Flow-Through Financing for Growth!
• Lennar Corporation Extends Exchange Offer Deadline for Shares
• Bakkt Transitions Board Leadership to Propel Future Growth
• FibroBiologics Focuses on Innovative Treatments for Chronic Diseases
• Lundin Gold Updates on Share Capital and Voting Rights Status
• Cellectis Sets Eye on Third Quarter Results Release
• Unitil Expands Footprint with Acquisition of Maine Natural Gas
• Lucas GC Limited: Strong Financial Performance in 2025
• TWC Enterprises Limited's Third Quarter Overview and Dividend Update
• Lucas GC Limited's Financial Growth and Strategic Outlook
• Skyharbour Resources Highlights Participation in Mining Showcase
• MagnaChip Semiconductor's Earnings Outlook: Investor Insights
• TWC Enterprises Reports Strong Q3 2025 Results and Dividend
• Insights on Reed's Upcoming Earnings and Stock Performance
• Colabor Group: Leadership Changes Enhance Corporate Governance